<DOC>
	<DOC>NCT02207777</DOC>
	<brief_summary>For this purpose, we will compare the effects of 16-18% weight loss induced by Roux-en Y Gastric bypass (RYGB) surgery, biliopancreatic diversion with duodenal switch (BPD), or sleeve gastrectomy (SG) surgeries with the same weight loss induced by laparoscopic adjustable gastric banding (LAGB) or a low-calorie diet (LCD) on liver and skeletal muscle insulin sensitivity, beta-cell function, and 24-hour metabolic homeostasis in obese subjects with T2D.</brief_summary>
	<brief_title>Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>RYGB/BPD/SG/LAGB Scheduled for one of these bariatric surgeries Body Mass Index (BMI) 3555 kg/m² Type 2 Diabetes and Non Diabetics Signed informed consent LowCalorie Diet BMI 3555 kg/m² Type 2 Diabetes and Non Diabetics Signed informed consent RYGB/BPD/SG &amp; LowCalorie Diet Regular use of tobacco products Previous intestinal resection Pregnant or breastfeeding Evidence of significant organ system dysfunction or disease other than T2D Use of any medication that might, in the opinion of the investigator, affect metabolic function Exercise &gt;= to 90 minutes per week</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Roux-en-Y gastric bypass (RYGB)</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Sleeve Gastrectomy (SG)</keyword>
	<keyword>Biliopancreatic Diversion with Duodenal switch (BPD)</keyword>
	<keyword>Laparoscopic Adjustable Gastric Banding (LAGB)</keyword>
</DOC>